| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $65.22M | - | |
| VP | 66.5K | $32.50M | - | |
| VP | 51.1K | $24.96M | - | |
| VP | 42.3K | $20.67M | - | |
| Other | 24.0K | $11.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,650 | $380.82 | $2,151,633.00 | -16.2% | +13.1% | +33.7% | |
| Nov 13, 2023 | Kewalramani Reshma55 | CEO &President | Sell | 5,097 | $377.00 | $1,921,569.00 | -4.3% | +10.5% | +29.3% | |
| Nov 6, 2023 | Sachs Bruce I51 | Director | Sale+OE | 11,250 | $385.00 | $4,331,250.00 | -22.0% | +11.2% | +29.6% | |
| Oct 31, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,651 | $355.92 | $2,011,303.92 | -13.9% | +20.4% | +31.2% | |
| Oct 17, 2023 | Bhatia Sangeeta N.48 | Director | Sell | 243 | $375.00 | $91,125.00 | -5.9% | +17.1% | +30.5% | |
| Oct 17, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,651 | $373.25 | $2,109,235.75 | -12.2% | +17.1% | +30.5% | |
| Oct 16, 2023 | Leiden Jeffrey M47 | Executive Chairman | Sell | 12,962 | $374.00 | $4,847,788.00 | -36.6% | +17.0% | +29.5% | |
| Oct 6, 2023 | Bhatia Sangeeta N.48 | Director | Sell | 242 | $360.00 | $87,120.00 | -5.5% | +15.4% | +26.3% | |
| Oct 3, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,651 | $345.28 | $1,951,177.28 | -10.9% | +19.1% | +33.9% | |
| Oct 2, 2023 | Biller Jonathan46 | EVP And Chief Legal Officer | Sell | 610 | $346.76 | $211,523.60 | -5.5% | +18.1% | +35.1% |